Literature DB >> 26614661

T-cells require post-transcriptional regulation for accurate immune responses.

Fiamma Salerno1, Monika C Wolkers2.   

Abstract

Cytotoxic T-cells are crucial to protect us from intracellular pathogens and malignant cells. When T-cells become activated, they rapidly secrete cytokines, chemokines and cytotoxic granules that are critical to clear infected cells. However, when not properly regulated, these toxic effector molecules become one of the key mediators of autoimmune diseases. Therefore, a tight and multi-layered regulation of gene expression and protein production is required to ensure a protective yet balanced immune response. In this review, we describe how post-transcriptional events modulate the production of effector molecules in T-cells. In particular, we will focus on the role of cis-regulatory elements within the 3'-UTR of specific mRNAs and on RNA-binding proteins (RBPs) and non-coding RNAs that control the initiation and resolution of T-cell responses.
© 2015 Authors; published by Portland Press Limited.

Entities:  

Keywords:  T cells; cytokines; post-transcriptional regulation

Mesh:

Substances:

Year:  2015        PMID: 26614661     DOI: 10.1042/BST20150154

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  9 in total

1.  Critical role of post-transcriptional regulation for IFN-γ in tumor-infiltrating T cells.

Authors:  Fiamma Salerno; Aurelie Guislain; Julian J Freen-Van Heeren; Benoit P Nicolet; Howard A Young; Monika C Wolkers
Journal:  Oncoimmunology       Date:  2018-10-22       Impact factor: 8.110

Review 2.  CD8+ T cell states in human cancer: insights from single-cell analysis.

Authors:  Anne M van der Leun; Daniela S Thommen; Ton N Schumacher
Journal:  Nat Rev Cancer       Date:  2020-02-05       Impact factor: 60.716

3.  Distinct PKC-mediated posttranscriptional events set cytokine production kinetics in CD8+ T cells.

Authors:  Fiamma Salerno; Nahuel A Paolini; Regina Stark; Marieke von Lindern; Monika C Wolkers
Journal:  Proc Natl Acad Sci U S A       Date:  2017-08-23       Impact factor: 11.205

Review 4.  CRISPR/Cas9 revitalizes adoptive T-cell therapy for cancer immunotherapy.

Authors:  Sasan Ghaffari; Nastaran Khalili; Nima Rezaei
Journal:  J Exp Clin Cancer Res       Date:  2021-08-26

Review 5.  MHC Class III RNA Binding Proteins and Immunity.

Authors:  Geraldine Schott; Mariano A Garcia-Blanco
Journal:  RNA Biol       Date:  2020-12-20       Impact factor: 4.652

Review 6.  Post-transcriptional control of T-cell cytokine production: Implications for cancer therapy.

Authors:  Julian J Freen-van Heeren
Journal:  Immunology       Date:  2021-05-10       Impact factor: 7.215

Review 7.  Using CRISPR to enhance T cell effector function for therapeutic applications.

Authors:  Julian J Freen-van Heeren
Journal:  Cytokine X       Date:  2020-12-21

Review 8.  CD8+ T cell differentiation and dysfunction in cancer.

Authors:  Mary Philip; Andrea Schietinger
Journal:  Nat Rev Immunol       Date:  2021-07-12       Impact factor: 108.555

9.  Human T cells employ conserved AU-rich elements to fine-tune IFN-γ production.

Authors:  Julian J Freen-van Heeren; Branka Popović; Aurélie Guislain; Monika C Wolkers
Journal:  Eur J Immunol       Date:  2020-03-18       Impact factor: 5.532

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.